Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Holly Kordasiewicz is an Executive Director in the Neuroscience Drug Discovery Department at Ionis Pharmaceuticals. Holly heads a team focused on identifying antisense oligonucleotide therapeutics for neurodegenerative diseases, including Huntington’s disease (HD). Holly joined Ionis 6 years ago after working on the pre-clinical validation for the HD program as a post-doctoral fellow in the laboratory of Dr. Don Cleveland at UCSD. Holly began her work on polyglutamine diseases at the University of Minnesota, where she received her Ph.D. in Neuroscience and studied the underlying disease mechanisms of SCA6.